(Q40251128)

English

Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells

scientific article published on 25 July 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Scott M Dehm

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Donald J Tindall

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

25 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

281

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

27882-27893

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Androgen receptor in prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

National Comprehensive Cancer Network guidelines for the management of prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

The development of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Androgen receptor signaling in androgen-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Androgen receptors and their biology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Transcriptional coactivator complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Identification of two transcription activation units in the N-terminal domain of the human androgen receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

The FXXLF motif mediates androgen receptor-specific interactions with coregulators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

p300 modulates nuclear morphology in prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Expression and function of androgen receptor coactivators in prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Pharmacodynamics of selective androgen receptor modulators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M605002200

21 January 2018

Identifiers

10.1074/JBC.M605002200

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40251128&oldid=2199635358"